Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents-Reference-Cited by-同舟云学术

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents

Published:2023-04-05 Issue:5 Volume:62 Page:749-759
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Zhang Tan^ORCID,Smit Cornelis^ORCID,Sherwin Catherine M. T.^ORCID,Knibbe Catherijne A. J.^ORCID,Krekels Elke H. J.^ORCID

Funder

China Scholarship Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-023-01227-5.pdf

Reference47 articles.

1. Centers for Disease Control and Prevention (CDC). Clinical growth charts [online]. https://www.cdc.gov/growthcharts/clinical_charts.htm. Accessed 25 July 2022.

2. Smit C, de Hoogd S, Brüggemann RJM, Knibbe CAJ. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275–85.

3. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4):S164–92.

4. Joseph PD, Craig JC, Caldwell PHY. Clinical trials in children. Br J Clin Pharmacol. 2015;79(3):357–69.

5. Engin A. The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017;960:1–17.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables?;The AAPS Journal;2024-05-09

2. Updated antimicrobial dosing recommendations for obese patients;Antimicrobial Agents and Chemotherapy;2024-05-02

3. How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing;Clinical Pharmacokinetics;2023-11-16